Placebo
NBI-1065846-MDD2020
Phase 2 small_molecule completed
Quick answer
Placebo for Anhedonia is a Phase 2 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Anhedonia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed